β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial
Top Cited Papers
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 358 (9295) , 1749-1753
- https://doi.org/10.1016/s0140-6736(01)06801-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Residual ß-cell function and microvascular complications in type 1 diabetic patientsBrazilian Journal of Medical and Biological Research, 2000
- Random C-peptide in the classification of diabetesScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Lack of association between early childhood immunizations and beta-cell autoimmunity.Diabetes Care, 1999
- T Cell Proliferative Responses of Type 1 Diabetes Patients and Healthy Individuals to Human hsp60 and its PeptidesJournal of Autoimmunity, 1999
- Islet T Cells Secreting IFN-γ in NOD Mouse Diabetes: Arrest by p277 Peptide TreatmentJournal of Autoimmunity, 1998
- Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of AutoantigensAnnual Review of Immunology, 1994
- Peptide therapy for diabetes in NOD miceThe Lancet, 1994
- Immunosuppression with Azathioprine and Prednisone in Recent-Onset Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Factors Associated with Early Remission of Type I Diabetes in Children Treated with CyclosporineNew England Journal of Medicine, 1988
- PARTIAL PRESERVATION OF PANCREATIC β-CELL FUNCTION IN CHILDREN WITH DIABETESThe Lancet, 1981